Clinical implications of TT virus superinfection in patients with chronic hepatitis C

American Journal of Gastroenterology

Volumn 95, Issue 7, 2000, Pages 1776-1780

  Watanabe, Hisayoshi ^a   Saito, Takafumi ^a   Kawamata, Osamu ^b   Shao, Li ^a   Aoki, Masanori ^a   Terui, Yuki ^a   Mitsuhashi, Hideki ^a   Matsuo, Taku ^a   Takeda, Yoshio ^a   Saito, Koji ^a   Togashi, Hitoshi ^a   Shinzawa, Haruhide ^a   Takahashi, Tsuneo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Ctr Molec Biol Cytogenet S   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SENSITIVITY; FEMALE; HEPATITIS C; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPERINFECTION; TORQUE TENO VIRUS; TREATMENT OUTCOME; VIREMIA; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; DNA VIRUS INFECTIONS; DNA VIRUSES; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RNA, VIRAL; SUPERINFECTION;

EID: 0033930618     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00969-2     Document Type: Article

References (34)

1. Mushahwar I.K., Erker J.C., Muerhoff A.S., et al. Molecular and biophysical characterization of TT virus; evidence for a new virus family infecting humans. Proc Natl Acad Sci USA. 96:1999;3177-3182.
2. Miyata H., Tsunoda H., Kazi A., et al. Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus. J Virol. 73:1999;3582-3586.
3. Nishizawa T., Okamoto H., Konishi K., et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. 241:1997;92-97.
4. Naoumov N.V., Petrova E.P., Thomas M.G., et al. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet. 352:1998;195-197.
5. Viazov S., Ross R.S., Varenholz C., et al. Lack of evidence for an association between TTV infection and severe liver disease. J Clin Virol. 11:1998;183-187.
6. Matsumoto A., Yeo A.E., Shih J.W.K., et al. Transfusion-associated TT virus infection and its relationship to liver disease. Hepatology. 30:1999;283-288.
7. Tagger A., Donato F., Ribero M.L., et al. A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma. Hepatology. 30:1999;294-299.
8. Watanabe H., Shinzawa H., Shao L., et al. Relationship of TT virus infection with prevalence of hepatitis C virus infection and elevated alanine aminotransferase levels. J Med Virol. 58:1999;235-238.
9. Umemura T., Tanaka E., Ota M., et al. TT virus infection in an area of high-endemicity of hepatitis C. Hepatol Res. 13:1999;212-220.
10. Schröter M., Feucht H.H., Zöllner B., et al. Prevalence of TTV viremia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany. Hepatol Res. 13:1999;205-211.
11. Orii K., Tanaka E., Umemura T., et al. Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis. Hepatol Res. 14:1999;161-170.
12. Cheng J., Hada T., Fukui K., et al. Detection of TTV DNA in serum of patients with chronic liver disease and interferon efficacy. Hepatol Res. 14:1999;97-104.
13. Chayama K., Kobayashi M., Tsubota A., et al. Susceptibility of TT virus to interferon therapy. J Gen Virol. 80:1999;631-634.
14. Akahane Y., Sakamoto M., Miyazaki Y., et al. Effect of interferon on a nonenveloped DNA virus (TT virus) associated with acute and chronic hepatitis of unknown etiology. J Med Virol. 58:1999;196-200.
15. Heid C.A., Stevens J., Livak K.J., et al. Real time quantitative PCR. Genome Res. 6:1996;986-994.
16. Takeuchi T., Katsume A., Tanaka T., et al. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology. 116:1999;636-642.
17. Martell M., Gómez J., Esteban J.I., et al. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol. 37:1999;327-332.
18. Mercier B., Burlot L., Férec C. Stimultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay. J Virol Methods. 77:1999;1-9.
19. Suzuki K., Shinzawa H., Kuboki M., et al. Secondary structure of the hepatitis C virus 5′ untranslated region and efficacy of interferon therapy for chronic hepatitis C. Liver. 18:1998;331-336.
20. Young K.K.Y., Resnick R.M., Myers T.W. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol. 31:1993;882-886.
21. Roth W.K., Lee J.H., Rüster B., et al. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J Clin Microbiol. 34:1996;261-264.
22. Widell A., Shev S., Mansson S., et al. Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers Epidemiological applications . J Med Virol. 44:1994;272-279.
23. Simmonds P., Holmes E.C., Cha T.A., et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 74:1993;2391-2399.
24. Okamoto H., Takahashi M., Nishizawa T., et al. Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology. 259:1999;428-436.
25. Kakinuma K., Yamauchi T., Hikiji K., et al. Development of the quantification method of TTV-DNA and clinical application. Nippon Rinsho. 57:1999;1262-1264.
26. Saito T., Shinzawa H., Uchida T., et al. Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B. J Med Virol. 58:1999;325-331.
27. Okamoto H., Nishizawa T., Kato N., et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res. 10:1998;1-16.
28. Fong T.L., Di Bisceglie A.M., Waggoner J.G., et al. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology. 14:1991;64-67.
29. Pontisso P., Ruvoletto M.G., Fattovich G., et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology. 105:1993;1529-1533.
30. Hino K., Sainokami S., Shimoda K., et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol. 42:1994;299-305.
31. Enomoto N., Sakuma I., Asahina Y., et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med. 334:1996;77-81.
32. Pawlotsky J.M., Pellerin M., Bouvier M., et al. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV) Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C . J Med Virol. 54:1998;256-264.
33. Ikeda H., Takasu M., Inoue K., et al. Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA. J Hepatol. 30:1999;205-212.
34. Kanda T., Yokosuka O., Ikeuchi T., et al. The role of TT virus infection in acute viral hepatitis. Hepatology. 29:1999;1905-1908.